Antonino Romeo

1.4k total citations
74 papers, 1.0k citations indexed

About

Antonino Romeo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Antonino Romeo has authored 74 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Antonino Romeo's work include Neuroblastoma Research and Treatments (7 papers), Brain Metastases and Treatment (5 papers) and Advanced Radiotherapy Techniques (5 papers). Antonino Romeo is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Brain Metastases and Treatment (5 papers) and Advanced Radiotherapy Techniques (5 papers). Antonino Romeo collaborates with scholars based in Italy, Spain and United States. Antonino Romeo's co-authors include Anna Negroni, Giuseppe Raschellà, Anna Sarnelli, Piero Cammarano, Claudio O. Gualerzi, Armando Felsani, Sérgio Ferrari, Sabina Pucci, Bruno Calabretta and Giovanni Finocchio and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Applied Physics Letters.

In The Last Decade

Antonino Romeo

64 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonino Romeo Italy 19 375 240 219 163 147 74 1.0k
Ho Sup Lee South Korea 20 385 1.0× 371 1.5× 151 0.7× 62 0.4× 110 0.7× 117 1.6k
Sean Knight United Kingdom 10 557 1.5× 271 1.1× 337 1.5× 201 1.2× 64 0.4× 17 1.2k
Jens Köhler Germany 22 398 1.1× 304 1.3× 397 1.8× 131 0.8× 42 0.3× 45 1.3k
Christopher McKenzie United Kingdom 17 233 0.6× 225 0.9× 194 0.9× 150 0.9× 121 0.8× 26 1.4k
Yuqiang Fang China 12 390 1.0× 336 1.4× 84 0.4× 261 1.6× 45 0.3× 23 895
Bernd Romeike Germany 28 720 1.9× 229 1.0× 236 1.1× 168 1.0× 323 2.2× 105 2.2k
Jung Wook Park United States 19 663 1.8× 652 2.7× 727 3.3× 317 1.9× 47 0.3× 28 1.5k
Lanlan Zhou United States 22 749 2.0× 543 2.3× 189 0.9× 331 2.0× 35 0.2× 101 1.9k
Hans J. Altermatt Switzerland 19 442 1.2× 564 2.4× 334 1.5× 267 1.6× 99 0.7× 30 1.5k
André Kajdacsy-Balla United States 17 257 0.7× 184 0.8× 59 0.3× 40 0.2× 61 0.4× 29 1.3k

Countries citing papers authored by Antonino Romeo

Since Specialization
Citations

This map shows the geographic impact of Antonino Romeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonino Romeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonino Romeo more than expected).

Fields of papers citing papers by Antonino Romeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonino Romeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonino Romeo. The network helps show where Antonino Romeo may publish in the future.

Co-authorship network of co-authors of Antonino Romeo

This figure shows the co-authorship network connecting the top 25 collaborators of Antonino Romeo. A scholar is included among the top collaborators of Antonino Romeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonino Romeo. Antonino Romeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merloni, Filippo, Michela Palleschi, Caterina Gianni, et al.. (2024). Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives. Clinical & Experimental Metastasis. 41(6). 863–875.
2.
Feliciani, Giacomo, et al.. (2024). Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck. Radiotherapy and Oncology. 204. 110703–110703. 1 indexed citations
3.
Merloni, Filippo, Michela Palleschi, Caterina Gianni, et al.. (2023). Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology. Frontiers in Oncology. 13. 1083297–1083297. 6 indexed citations
5.
Feliciani, Giacomo, Manuela Monti, Ignazio Stanganelli, et al.. (2022). A New Approach for a Safe and Reproducible Seeds Positioning for Diffusing Alpha-Emitters Radiation Therapy of Squamous Cell Skin Cancer: A Feasibility Study. Cancers. 14(1). 240–240. 5 indexed citations
6.
Zanoni, Michele, Alba Clara Sarti, Alice Zamagni, et al.. (2022). Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma. Cell Death and Disease. 13(1). 80–80. 35 indexed citations
7.
Neri, Elisa, et al.. (2021). Complete pathological response in locally advanced non-small-cell lung cancer patient: A case report. World Journal of Clinical Cases. 9(20). 5540–5546.
8.
Passardi, Alessandro, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.. (2021). Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies. Biomolecules. 11(8). 1200–1200. 3 indexed citations
10.
Caroli, Paola, Ugo De Giorgi, Monica Celli, et al.. (2020). 68Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy. Biomedicines. 8(12). 536–536. 11 indexed citations
11.
Passardi, Alessandro, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.. (2020). Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial. Therapeutic Advances in Medical Oncology. 12. 3863592179–3863592179. 1 indexed citations
12.
Passardi, Alessandro, Emanuela Scarpi, Elisa Neri, et al.. (2019). Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers. 11(5). 663–663. 9 indexed citations
13.
Conteduca, Vincenza, Giorgia Gurioli, Nicole Brighi, et al.. (2019). Plasma Androgen Receptor in Prostate Cancer. Cancers. 11(11). 1719–1719. 16 indexed citations
14.
Rossi, R, Emanuela Scarpi, Monia Dall’Agata, et al.. (2019). The challenge of prognostication in palliative radiotherapy: the way forward is shared decision-making. Supportive Care in Cancer. 28(4). 1545–1546. 1 indexed citations
15.
Milandri, Carlo, R. Polico, Domenico Garcea, et al.. (2011). GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.. PubMed. 58(106). 20–21. 7 indexed citations
16.
Finocchio, Giovanni, Mario Carpentieri, L. Torres, et al.. (2007). Numerical study of the magnetization reversal driven by spin-polarized current in MgO-based magnetic tunnel junctions. Physica B Condensed Matter. 403(2-3). 364–367.
17.
Zuo, Jianping, et al.. (2006). RP1L1 Is Required for Appropriate Outer Segment Formation. Investigative Ophthalmology & Visual Science. 47(13). 4749–4749. 2 indexed citations
18.
Viri, Maurizio, Rolando Cimaz, Monica Lodi, et al.. (1999). High prevalence of anticardiolipin and/or anti-beta2 glycoprotein i antibodies in young patients with epilepsy. The Italian Journal of Neurological Sciences. 20(5). 2 indexed citations
19.
Negroni, Anna, et al.. (1995). Requirement of B- myb Function for Survival and Differentiative Potential of Human Neuroblastoma Cells. Journal of Biological Chemistry. 270(15). 8540–8545. 65 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026